Examples of using Scientific discussion in English and their translations into Swedish
{-}
-
Medicine
-
Official
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Authorisation Holders have been assessed based on the documentation submitted and the scientific discussion within the Committee.
Authorisation Holders have been assessed based on the documentation submitted and the scientific discussion within the Committee.
prompting scientific discussion.
it has been carefully anchored in the social and scientific discussion.
Based on the documentation submitted by the Marketing Authorisation Holders and the scientific discussion within the Committee, the CPMP considered that the benefit/ risk ratio of calcium folinate(solution for injection
Based on the documentation submitted by the MAH and the scientific discussion within the Committee, the CHMP considered that the benefit/risk ratio of STAMARIL
The EU supports a more effective governance of the global environment through a more integrated structure in order to reinforce environmental standard setting, scientific discussion and monitoring of treaty compliance.
Benefit/ Risk considerations Based on the documentation submitted by the MAH and the scientific discussion within the Committee, the CPMP considered that the benefit/ risk ratio of Lopid is favourable for use relating to.
Based on the documentation submitted by the MAH and the scientific discussion within the Committee, the CHMP considered that the benefit/ risk ratio of neurontin
Benefit/Risk considerations Based on the documentation submitted by the MAH and the scientific discussion within the Committee, the CPMP considered that the benefit/risk ratio of Pravachol is favourable for use relating to.
The documentation submitted, the scientific discussion within the Committee and the new wording proposed in the updated Guideline on SPC dated October 2005
Documentation submitted including the proposal for a pregnancy prevention programme and the scientific discussion within the Committee, the CPMP has recommended the granting of the Marketing Authorisation with amendments of the Summary of Products Characteristics.
Based on the documentation submitted by the MAH and the scientific discussion within the Committee, the CPMP considered that the benefit/ risk ratio of Prograf and associated names is
the Co-Rapporteur assessment reports, the scientific discussion within the Committee and the comments from the Marketing Authorisation Holders(MAH), was of the
create an open scientific discussion platform so that all the relevant information is considered
Package Leaflet proposed by the Marketing Authorisation Holders has been assessed based on the documentation submitted and the scientific discussion within the Committee.
During its January 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that a marketing authorisation should be granted.
During its April 2003 meeting, the CPMP, in the light of the overall submitted data and the scientific discussion within the Committee, was of the opinion that the summary of product characteristics should be amended.
Benefit/ Risk considerations Based on the documentation submitted by the applicant including the proposal for implementation of a pregnancy prevention programme and the scientific discussion within the Committee, the CPMP considered that the benefit/ risk ratio of Isotretinoin/ Lurantal/ Rexidal/ Scheritonin/ Trivane is positive for the agreed indications.
Benefit/ Risk considerations Based on the documentation submitted by the Marketing Authorisation Holders including the proposal for implementation of a pregnancy prevention programme and the scientific discussion within the Committee, the CPMP considered that the benefit/ risk ratio of Roaccutane(and associated names) is positive for the agreed indications.